S Gastrointestinal And Liver Disease 12th Edition May 2026
The 12th Edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease
, scheduled for release in December 2025, is a comprehensive two-volume masterwork that serves as the definitive reference for gastroenterology and hepatology. Key Highlights of the 12th Edition
New Editorial Team: Guided by Raymond T. Chung, David T. Rubin, and C. Mel Wilcox.
Expanded Clinical Topics: Includes updated discussions on eosinophilic disorders, MASLD (Metabolic dysfunction-associated steatotic liver disease), and the latest treatments for inflammatory bowel disorders (IBD).
Technological Advances: Features the use of AI in endoscopy for GI cancer detection and new sections on molecular diagnostics.
Modern Pathology: New chapters covering COVID-19 manifestations in the GI tract and liver, as well as cancer immunotherapy-induced enterocolitis and hepatitis.
Multimedia Integration: Over 1,100 full-color illustrations and more than 20 procedural videos are included in the enhanced eBook version. Table of Contents (Summary of Major Parts)
The textbook is organized logically across 11 primary sections comprising 132 chapters:
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Sleisenger and Fordtran's Gastrointestinal and Liver Disease: 12th Edition – The Gold Standard in Gastroenterology
For over fifty years, one textbook has stood above all others as the definitive source for clinical gastroenterology and hepatology. The release of Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition, continues this legacy, providing a comprehensive, evidence-based foundation for clinicians, fellows, and residents worldwide.
In an era where medical knowledge evolves at a breakneck pace, the 12th edition arrives as an essential update, bridging the gap between cutting-edge research and bedside practice. What’s New in the 12th Edition?
The 12th edition isn't just a reprint; it is a thorough overhaul designed to reflect the current landscape of digestive health. 1. Advanced Microbiome Insights
Our understanding of the human gut microbiome has exploded. This edition integrates the latest science on how microbial communities influence everything from Inflammatory Bowel Disease (IBD) to metabolic disorders and liver health. 2. Precision Medicine and Genetics s gastrointestinal and liver disease 12th edition
The shift toward personalized care is a major theme. The text explores genetic markers, biological therapies, and targeted treatments that allow physicians to move beyond a "one size fits all" approach to complex diseases. 3. Expanded Hepatology Coverage
With the rise of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—formerly NAFLD—and breakthroughs in Hepatitis C and cirrhosis management, the liver sections have been significantly expanded to provide the most current clinical pathways. 4. Minimally Invasive Innovations
The 12th edition highlights the latest in diagnostic and therapeutic endoscopy, including EUS (Endoscopic Ultrasound) and ERCP, as well as the expanding role of robotic surgery in gastrointestinal care. Core Features That Set It Apart
Multidisciplinary Approach: Content is curated by a world-class team of editors (Mark Feldman, Lawrence S. Friedman, and Lawrence J. Brandt) and hundreds of expert contributors, ensuring a balanced view from both medical and surgical perspectives.
Radiology and Pathology Integration: Thousands of high-quality illustrations, anatomical drawings, and clinical photos help clinicians correlate symptoms with visual findings.
Summary Tables and Algorithms: For the busy practitioner, the 12th edition utilizes clear, concise tables and treatment algorithms that make decision-making faster and more accurate.
Comprehensive Evidence Base: Every chapter is backed by the most recent clinical trials and consensus guidelines, making it the primary reference for board exams and certification. Why Every GI Specialist Needs the 12th Edition
Whether you are a seasoned gastroenterologist or a trainee preparing for the boards, this textbook serves as a "living" document of the field. It covers the full spectrum of digestive health:
Esophageal and Gastric Disorders: From GERD and motility issues to peptic ulcer disease.
Small and Large Intestine: Deep dives into Celiac disease, Crohn’s, Ulcerative Colitis, and IBS.
Pancreatico-Biliary System: Comprehensive management of pancreatitis and gallstone disease.
Liver Disease: Updates on transplantation, autoimmune hepatitis, and oncology. Conclusion
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition remains the most trusted encyclopedia of the digestive system. By combining foundational pathophysiology with the latest technological and pharmacological breakthroughs, it ensures that practitioners are equipped to provide the highest level of patient care. Comparison to Other Major GI Textbooks | Feature
In the complex and ever-changing world of gastroenterology, this is the one resource you cannot afford to be without.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
12th Edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease released on December 10, 2025
. This comprehensive update to the "definitive GI reference" introduces several new clinical chapters and reflects major shifts in the management of digestive and hepatic conditions. Key Updates & New Content The latest edition, edited by experts like Raymond T. Chung David T. Rubin , features significant expansions: Novel Pathologies: New chapters covering Gastrointestinal and Hepatic Manifestations of COVID-19 Enterocolitis and Hepatitis Induced by Cancer Immunotherapy Advanced Technology: Detailed discussion on the use of AI in endoscopy to improve the detection of GI cancers. Updated Terminology: Comprehensive coverage of
(Metabolic dysfunction-associated Steatotic Liver Disease), reflecting the shift from the former NAFLD nomenclature. Therapeutic Advances: Updates on new treatments for viral hepatitis
, autoimmune liver diseases, and the expanding array of biologics for inflammatory bowel disorders (IBD) Clinical Utility
Designed for both seasoned clinicians and fellows, the 12th edition includes: Visual Learning: 1,000 illustrations and photographs, with 400 in full color. Procedural Content: 35 new procedural videos through the digital version. Decision Support: quick-reference algorithms to assist in bedside clinical decision-making. Google Books
The book is available through major medical retailers such as Barnes & Noble new management algorithms included for a specific disease, such as
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease - Elsevier
For more than 50 years, Sleisenger and Fordtran's Gastrointestinal and Liver Disease
has remained the definitive reference for gastroenterology and hepatology professionals. The upcoming 12th Edition , scheduled for release in December 2025
, provides a comprehensive two-volume update on the pathophysiology, diagnosis, and management of GI and liver conditions. Key Features and Updates Part IV: Small Intestine
The 12th edition is guided by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox . Major updates include: US Elsevier Health New Clinical Discussions
: Expanded coverage of eosinophilic disorders, autoimmune liver diseases, and the latest treatments for viral hepatitis. Renamed Conditions : Incorporation of new terminology, such as
(metabolic dysfunction-associated steatotic liver disease), formerly known as NAFLD. New Chapters
: Dedicated sections on the gastrointestinal and hepatic manifestations of , as well as enterocolitis and hepatitis induced by cancer immunotherapy Advanced Technology : Updated insights into the use of AI in endoscopy for improved detection of GI cancers. Visual and Practical Aids : Over 1,100 full-color illustrations and more than 20 procedural videos
covering endoscopic techniques like balloon dilatation and stent placement. Reference Details Elsevier Health Sciences Publication Date 10–15 December 2025 978-0443116575 Page Count Approx. 2,500–3,700 pages (2-Volume Set) Target Audience
Gastroenterologists, hepatologists, residents, fellows, and medical students Availability and Pricing
The 12th edition is available for pre-order at several retailers: Elsevier Health : Offers the Complete 2-Volume Set for approximately ₹31,844 : Lists the hardcover 2-volume set at for ₹20,750. Specialized Medical Bookstores : Retailers like Naresh Book Store (₹20,485) and (₹20,999 ) offer pre-publication pricing. US Elsevier Health digital eBook access included with this edition?
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
This is a request for a detailed content outline / chapter breakdown for a hypothetical 12th edition of a major textbook like Sleisenger and Fordtran’s Gastrointestinal and Liver Disease.
Since I cannot reproduce the full copyrighted text of the actual 11th or 12th edition, I have generated a highly realistic, structured, and publication-ready blueprint for what the 12th edition would contain, including new emerging topics (gut microbiome, AI in endoscopy, RNA therapeutics) that would distinguish it from prior editions.
Below is a solid, professional-grade content generator for study, curriculum mapping, or editorial planning.
Comparison to Other Major GI Textbooks
| Feature | Sleisenger & Fordtran (12th) | Yamada’s Textbook of Gastroenterology (7th) | Zakim & Boyer’s Hepatology (7th) | |--------|-------------------------------|-----------------------------------------------|-------------------------------------| | Focus | Full GI + Hepatology | Full GI + Hepatology | Hepatology only (but comprehensive) | | Style | Dense, encyclopedic | Slightly more narrative | Highly detailed liver-focused | | Best for | Board exam prep, clinical reference | Teaching, fellows’ reading | Hepatologists, liver transplant teams | | Images | Excellent (clinical + pathology) | Good | Superior liver histology and radiology | | Digital | Expert Consult (good) | Online access (comparable) | Included with print |
Part IV: Small Intestine
- Celiac Disease (new: non-responsive celiac, novel biologics)
- SIBO & Intestinal Methanogen Overgrowth (new: rifaximin, elemental diets)
- Short Bowel Syndrome (updated: GLP-2 analogs – teduglutide, apraglutide)
1. Expanded Coverage of the Gut-Brain Axis and Functional Disorders
Functional GI disorders (IBS, functional dyspepsia) are no longer considered "diagnoses of exclusion." The new edition integrates the latest Rome IV criteria and dedicates entire chapters to the neuroscience of the gut-brain axis. You will find updated algorithms for managing refractory IBS, including the role of dietary interventions (low FODMAP), gut-directed hypnotherapy, and novel pharmacological agents like tenapanor and ibodutant.
High-Quality Imaging and Video Support
The text is integrated with an online companion site (access code included with purchase) featuring:
- Over 1,500 figures, many in vibrant color.
- Video clips of endoscopic procedures, including polypectomy, variceal banding, and peroral cholangioscopy.
- Histopathology slides correlating endoscopic findings with microscopic disease.
Target Audience
- Gastroenterology Fellows: An indispensable resource for board certification preparation. The question bank (often associated with the digital platform) is a key study tool.
- Practicing Clinicians: A reference for managing complex cases that fall outside the scope of daily routine.
- GI Surgeons: Essential reading for understanding the medical management of pre- and post-operative patients.